Literature DB >> 5047141

Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.

I Parr.   

Abstract

The responses of four murine lymphomata, transplanted in their syngeneic hosts and differing widely in their biological properties such as tendency to metastasize and "strength" of tumour specific antigen, to immunotherapy, were investigated. Following the injection of a known number of tumour cells, the mice were treated either by administration of irradiated tumour cells, living BCG or both. In general, the response to BCG alone was small even in the most responsive tumours, irradiated cells were more effective and the best results were obtained by a combination of the two procedures. "Cures" were only obtained with the most antigenic of the tumours tested and then only when the live tumour cells were inoculated intraperitoneally. The effect of these treatments on the rate of growth of tumour when the cells were given subcutaneously was small but the rate at which metastatic spread occurred from the s.c. site was slowed and for one of these tumours this was quite marked.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5047141      PMCID: PMC2008478          DOI: 10.1038/bjc.1972.24

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  AN IMMUNOLOGICAL METHOD OF INCREASING THE SENSITIVITY OF PRIMARY SARCOMAS TO LOCAL IRRADIATION WITH X RAYS.

Authors:  A HADDOW; P ALEXANDER
Journal:  Lancet       Date:  1964-02-29       Impact factor: 79.321

2.  The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour.

Authors:  P Alexander; J Bensted; E J Delorme; J G Hall; J Hodgett
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-11-18

3.  Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas.

Authors:  G A Currie
Journal:  Br Med J       Date:  1970-02-28

4.  Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Authors:  G Mathé; P Pouillart; F Lapeyraque
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

5.  Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

Authors:  M F Woodruff; J L Boak
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

  5 in total
  31 in total

1.  Editorial: BCG in cancer.

Authors: 
Journal:  Br Med J       Date:  1976-06-19

2.  Failure of BCG immunostimulation to affect the clinical course of Burkitt's lymphoma.

Authors:  I T Magrath; J L Ziegler
Journal:  Br Med J       Date:  1976-03-13

3.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

4.  Clonal analysis of expression of tumor-associated transplantation antigens and of metastatic capacity.

Authors:  V Schirrmacher; K Bosslet
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

Review 5.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Selection and isolation of a new variant of DBA/2 mastocytoma P 815 X 2.

Authors:  G Bandlow; R Härtl
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

7.  Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.

Authors:  E S Dye; R J North; C D Mills
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

8.  Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy.

Authors:  R L Powles; T A Lister; R T Oliver; J Russell; C Smith; H E Kay; T J McElwain; G H Fairley
Journal:  Br Med J       Date:  1974-11-16

9.  Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial.

Authors:  W R Klein; G E Bras; W Misdorp; P A Steerenberg; W H de Jong; R H Tiesjema; A W Kersjes; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.

Authors:  R Bomford
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.